Latest News

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 4

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 5

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 6

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 7

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 8

ITIs are qualitative, semi-structured interviews conducted with clinical trial participants
to capture their personal experiences of disease and treatment.

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 9

A paradigm shift is taking place in medicine: health is increasingly understood holistically – as an interplay of physical, mental and social factors.

Highlights Count-Down to 10 Years admedicum in June 2026 Nr. 10

Clinical trials are the engine of medical innovation, but they can’t move forward without the people who join them.

ITIs are qualitative, semi-structured interviews conducted with clinical trial participants to capture their personal experiences of disease and treatment.

Strengthen your recruitment outcomes and make clinical trials truly patient-relevant.

Clinical trials are the engine of medical innovation—but they can’t move forward without the people who join them.

Under the EU’s Joint Clinical Assessment (JCA), patient engagement is no longer optional - it’s a prerequisite for successful market and patient access.

Kirsty Cullen, Chief Executive of the Optimum Health Clinic in London, UK is passionate about raising awareness about complex fatigue-related illness and the integrative approach developed to optimize care.

ENPADE Survey Findings Published

From a LinkedIn Live session held on Feb. 6, 2025

In the rapidly evolving landscape of healthcare and medical research, patient engagement has become more than just a buzzword.

In this inspiring episode, host Roger Legtenberg welcomes Trish Bartley, a true pioneer in bringing mindfulness to people with cancer.

10 key considerations

The European healthcare landscape is undergoing a profound transformation due to the Joint Clinical Assessment.

We're in the midst of a new era of patient engagement, where patients are taking an active role in their own care.

Second edition of Patients and Industry in Milan with patient organisations, caregivers and industry representatives.

In the evolving healthcare landscape, patient involvement is becoming a critical element in decision-making processes, particularly in Health Technology Assessment (HTA) across Europe.

In this enlightening 8th episode of the Patients on the Move Podcast, host Roger Legtenberg sits down with Jennifer MacDonald.

In this enlightening 7th episode of the Patients on the Move Podcast, host Roger Legtenberg sits down with Pisana Ferrari.

In this enlightening 8th episode of the Patients on the Move Podcast, host Roger Legtenberg sits down with Steve Clark.

In the dynamic world of medical research, clinical trials are crucial for pioneering effective treatments.

Our online event examined the current landscape of patient advocacy and engagement across Latin America, with a keen focus on Colombia and Brazil.

The Pazienti e Industrie event in Milan brought together >40 participants from patient organizations, caregivers & industry representatives.

In the rapidly evolving healthcare industry, there is a noticeable and positive shift towards a patient-centered approach, with a strong emphasis on empathy.

In this enlightening 5th episode of the Patients on the Move Podcast, host Roger Legtenberg sits down with Jaime Sanders, aka 'The Migraine Diva'.

In the dynamic world of clinical development, one fact is undeniable: the patient voice is critical.

admedicum is pleased to support World Pulmonary Hypertension Day and would like to share our new project role as Secretariat for the Alliance for Pulmonary Hypertension.

In this episode Bojana and Philipp discussed how patient advocacy & patient engagement can help prepare patient access.

Why we may develop "blind spots” when living with a chronic disease... Philipp von Gallwitz tells his personal story.

Tom and Andreas share their thoughts on the roles & best practices for patient involvement in HTA processes.

Why patient engagement is even more important than in “traditional” therapies!

admedicum, together with friends (family, collaborators, clients), participated in the 2nd edition of the Rare Diseases Run in Aachen, Amsterdam, and Cologne.

More than fifty participants responded to the invitation of admedicum and the French patient organizations Corasso and Seintinelles.

We are very pleased to welcome Tiziana Scanu as Patient Engagement Manager.

At the beginning of this year, we took the time once more to reflect on our major learnings and most inspiring experiences from a selection of meetings and conferences

Much more than ever before, the use of digital solutions and apps is high on the agenda in many board rooms and executive offices of pharmaceutical companies.

patient2care is a knowledge platform developed through co-creation with & for patients.

More than one-third of clinical trial budgets is spent on recruitment and about one-third of the trials are ultimately cancelled due to insufficient participation.

"Patients on the Move!" is a brand-new podcast about Patient Engagement in Life Sciences by admedicum – PATIENT DRIVEN SOLUTIONS.

The debate took place as part of the networking session organized by the Spanish Association for Lysosomal Diseases and admedicum.

Why it matters to obtain patient insights along the digital health app and DTx development journey

Ella Balasa and Dr. Andreas Reimann hosted a live discussion on Patient inclusion in clinical trial design – why it matters and how you can get started

"Patients on the Move!" is a brand-new podcast about Patient Engagement in Life Sciences by admedicum – PATIENT DRIVEN SOLUTIONS.

Looking back at the Patient Engagement in 2030 symposium

Call for participation!

Technology combined with unmatched patient engagement services to create successful patient recruitment strategies, trial awareness and boosted enrollment

admedicum has been recognized as a key player in the field of Patient Engagement in the 2022 Biotechnology Awards programme of the Global Health and Pharma magazine

We are very pleased to welcome Vera Vennedey as Patient Engagement Consultant!

While there has been a centralized European marketing authorization procedure for years, Health Technology Assessments (HTA) remained decentralized at state level.

The European Alliance for Newborn Screening in Spinal Muscular Atrophy (SMA NBS Alliance) was founded in 2020 by SMA Europe and a group of diverse stakeholders.

admedicum is proud to support the European Alliance for Spinal Muscular Atrophy Newborn Screening in its role as the Secretariat.

We are excited to announce the opening of admedicum Paris, France!

Patients with rare or complex diseases are often overwhelmed when it comes to finding their way in the healthcare system.

Hopefully you share our perspective that patient engagement should be fully integrated into drug development.

REFER is a project from the Innovative Medicines Initiative (IMI). "IMI is the world's biggest public-private partnership in the life sciences.

In a number of projects admedicum and Justin Stindt Consulting have already successfully merged their expertise. The companies now are combining their skills tighter to create value for both patients and industry.

It’s time for Europe to bridge the gap in newborn screening for spinal muscular atrophy.

The patient association MPS España and the patient engagement expert group admedicum Business for Patients are excited to announce their strategic partnership.

Nine patient representatives from nine different countries all around Europe are talking about 2020 and giving a hopeful outlook for 2021.

We take immense pride in being recognized by BioNTech SE for having been part of the unprecedented "project lightspeed" that eventually brought the first evidence-based and approved COVID-19 vaccine to the global population.

admedicum, a patient engagement expert consulting company, today announced their strategic expansion into the Netherlands and strengthening their leadership team.

Aparito and admedicum co-organised a roundtable with ten participants from the sector to discuss how decentralised trials can effectively collect data. Read the full summary.

Opening a new horizon for children born with SMA.

Some companies may still struggle with a question that may sound simple but can be really tricky when it comes to acting.

Sponsors need to engage with patients on any protocol design changes and actively communicate the change to minimize dropouts.

admedicum Business for Patients organized a series of small roundtables with patient and industry experts. This an anonymized summary of those conversations in order to help you with your own decision making.

Some companies may ask themselves whether they can actually work together with patients. The clear and simple answer to that is: YES, they are!